Original Research

Published on 22 Jun 2023

PD-L1 and tumor-infiltrating CD8+ lymphocytes are correlated with clinical characteristics in pediatric and adolescent pituitary adenomas

in Cancer Endocrinology

Mengwu Shi
Yifu Song
Yaochuan Zhang
Longjie Li
Juanhan Yu
Ana Hou
Sheng Han

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1151714

2,200 views
4 citations

Original Research

Published on 21 Jun 2023

Progestin plus metformin improves outcomes in patients with endometrial hyperplasia and early endometrial cancer more than progestin alone: a meta-analysis

in Cancer Endocrinology

Fengping Shao
Yinguang Li
Yunhe Zhao

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1139858

4,434 views
4 citations

Original Research

Published on 21 Jun 2023

Association between diabetes status and breast cancer in US adults: findings from the US National Health and Nutrition Examination Survey

in Cancer Endocrinology

Xingyu Sun
Qiangsong Zhang
Kaisaierjiang Kadier
Pengcheng Hu
Xiaozhu Liu
Jialing Liu
Yulu Yan
Chenyu Sun
Vicky Yau
Scott Lowe

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1059303

7,593 views
4 citations

Original Research

Published on 09 Jun 2023

Glucose-dependent effect of insulin receptor isoforms on tamoxifen antitumor activity in estrogen receptor-positive breast cancer cells

in Cancer Endocrinology

Stefania Stella
Michele Massimino
Livia Manzella
Nunziatina Laura Parrinello
Silvia Rita Vitale
Federica Martorana
Paolo Vigneri

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1081831

2,415 views
1 citation

Editorial

Published on 09 Jun 2023

Editorial: Sphingolipid metabolism dysfunction in cancer

in Cancer Endocrinology

Rashika El Ridi
Jingjing Duan
Junfei Jin

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1208616

2,122 views

Original Research

Published on 08 Jun 2023

Validation of miRNAs as diagnostic and prognostic biomarkers, and possible therapeutic targets in medullary thyroid cancers

in Cancer Endocrinology

Alberto Mondin
Loris Bertazza
Susi Barollo
Maria Chiara Pedron
Jacopo Manso
Ilaria Piva
Daniela Basso
Isabella Merante Boschin
Maurizio Iacobone
Raffaele Pezzani

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1151583

1,781 views
3 citations

Review

Published on 08 Jun 2023

Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets

in Cancer Endocrinology

Yinshuang Chen
Weipeng Wang
Maria P. Morgan
Tracy Robson
Stephanie Annett

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1148934

8,652 views
17 citations

Review

Published on 06 Jun 2023

Metabolic reprogramming of clear cell renal cell carcinoma

in Cancer Endocrinology

Haiyan Zhu
Xin Wang
Shihao Lu
Kongbo Ou

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1195500

5,705 views
16 citations

Original Research

Published on 06 Jun 2023

Network pharmacology and bioinformatics analysis identifies potential therapeutic targets of Naringenin against COVID-19/LUSC

in Cancer Endocrinology

Wen-yu Wu
Xin Jiao
Wen-xin Song
Peng Wu
Pei-qi Xiao
Xiu-fang Huang
Kai Wang
Shao-feng Zhan

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1187882

5,783 views
8 citations

Original Research

Published on 02 Jun 2023

Characteristics and factors influencing hypothalamic pituitary dysfunction in patients with craniopharyngioma

in Cancer Endocrinology

Ying Guo
Lili Pei
Yuzheng Li
Chunde Li
Songbai Gui
Ming Ni
Pinan Liu
Yazhuo Zhang
Liyong Zhong

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1180591

2,537 views
9 citations

Original Research

Published on 02 Jun 2023

Construction of a telomere-related gene signature to predict prognosis and immune landscape for glioma

in Cancer Endocrinology

Qin Xie
Tingting Liu
Xiaole Zhang
Yanli Ding
Xiaoyan Fan

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1145722

2,143 views
2 citations

Review

Published on 02 Jun 2023

Endocrine disrupting and carcinogenic effects of decabromodiphenyl ether

in Cancer Endocrinology

Yi Wang
Xinpei Wang
Shaofeng Sui
Zhiyan Liu

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1183815

2,423 views
5 citations

Original Research

Published on 31 May 2023

Patient decision aids for patients with differentiated thyroid carcinoma: development process and alpha and beta testing

in Cancer Endocrinology

Anna Koot
Rosella Hermens
Petronella Ottevanger
Romana Netea-Maier
Peep Stalmeier
the COMBO study group
Marieke Snel
Noortje van der Kleij-Corssmit
Johannes Bonenkamp
Koen Dreijerink

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1162537

2,111 views
1 citation

Original Research

Published on 29 May 2023

Clinico-cytopathological subcategorization in thyroid nodules of atypia of undetermined significance/follicular lesion of undetermined significance using the TIRADS and Bethesda classifications

in Cancer Endocrinology

Amirhesam Babajani
Saeed Rahmani
Masoomeh Raoufi
Elham Shaarbaf Eidgahi
Amirreza Vahid Dastjerdi
Poya Behfarnia
Shayesteh Khalili
Noushin Afshar Moghaddam

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1135196

7,566 views
5 citations

Original Research

Published on 26 May 2023

Effect of surgical treatment on patients with stage T3 or T4 triple-negative breast cancer: a SEER-based retrospective observational study

in Cancer Endocrinology

Jie Hu
Changling Dai
Yang Zhang
Weijun Chen
Lihua Sun
Xu Zhang
Minjie Duan
Hao Fu
Teng Long
Wei Kang

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1184173

2,728 views

Systematic Review

Published on 26 May 2023

Precision radiotherapy using MR-linac for pancreatic neuroendocrine tumors in MEN1 patients (PRIME): a protocol for a phase I-II trial, and systematic review on available evidence for radiotherapy of pNETs

in Cancer Endocrinology

Eline N. M. van Vliembergen
Hidde Eijkelenkamp
Gerlof D. Valk
Menno R. Vriens
Gert J. Meijer
Martijn P. W. Intven
Joanne M. de Laat

Frontiers in Endocrinology

doi 10.3389/fendo.2023.994370

3,158 views
1 citation

Navigation group

Articles

PD-L1 and tumor-infiltrating CD8+ lymphocytes are correlated with clinical characteristics in pediatric and adolescent pituitary adenomas

Progestin plus metformin improves outcomes in patients with endometrial hyperplasia and early endometrial cancer more than progestin alone: a meta-analysis

Association between diabetes status and breast cancer in US adults: findings from the US National Health and Nutrition Examination Survey

Glucose-dependent effect of insulin receptor isoforms on tamoxifen antitumor activity in estrogen receptor-positive breast cancer cells

Editorial: Sphingolipid metabolism dysfunction in cancer

Validation of miRNAs as diagnostic and prognostic biomarkers, and possible therapeutic targets in medullary thyroid cancers

Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets

Metabolic reprogramming of clear cell renal cell carcinoma

Network pharmacology and bioinformatics analysis identifies potential therapeutic targets of Naringenin against COVID-19/LUSC

Characteristics and factors influencing hypothalamic pituitary dysfunction in patients with craniopharyngioma

Construction of a telomere-related gene signature to predict prognosis and immune landscape for glioma

Endocrine disrupting and carcinogenic effects of decabromodiphenyl ether

Patient decision aids for patients with differentiated thyroid carcinoma: development process and alpha and beta testing

Clinico-cytopathological subcategorization in thyroid nodules of atypia of undetermined significance/follicular lesion of undetermined significance using the TIRADS and Bethesda classifications

Effect of surgical treatment on patients with stage T3 or T4 triple-negative breast cancer: a SEER-based retrospective observational study

Precision radiotherapy using MR-linac for pancreatic neuroendocrine tumors in MEN1 patients (PRIME): a protocol for a phase I-II trial, and systematic review on available evidence for radiotherapy of pNETs